Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| U S PHYSICAL THERAPY INC /NVUSPH · Entity 379 | Director | December 16, 2022 | December 19, 2022 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
U S PHYSICAL THERAPY INC /NV
Report date December 16, 2022 · Filed December 19, 2022
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 6,740 |
Reported balance
After 2022-12-16 transaction · row 1
Account or security details depend on footnotes; rows are not merged.
1 source rowRow 1 · 2022-12-16 · Sale · Disposed 4,160 · Balance 6,740 F1: The price reported is a weighted average price $84.09 The shares were sold in multiple transactions at prices ranging from $84.00 to $84.90 per share, both inclusive. The reporting person undertakes to provide to U.S. Physical Therapy, Inc., any of its shareholders or the staff of the Securities & Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote to this Form 4. F2: Includes 800 shares of common stock which were granted as restricted stock pursuant to the Company Amended and Restated 2003 Stock Incentive Plan. Restrictions will lapse on the 400 shares on January 1, 2023, and 400 shares on April 1, 2023, if he is a director of the Company on that date. |
Filing footnotes · ownership attribution and instrument terms
F1: The price reported is a weighted average price $84.09 The shares were sold in multiple transactions at prices ranging from $84.00 to $84.90 per share, both inclusive. The reporting person undertakes to provide to U.S. Physical Therapy, Inc., any of its shareholders or the staff of the Securities & Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote to this Form 4.
F2: Includes 800 shares of common stock which were granted as restricted stock pursuant to the Company Amended and Restated 2003 Stock Incentive Plan. Restrictions will lapse on the 400 shares on January 1, 2023, and 400 shares on April 1, 2023, if he is a director of the Company on that date.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| December 16, 2022 Filed Dec 19, 2022 17:21 UTC | U S PHYSICAL THERAPY INC /NV USPH · Entity 379 | SaleCommon Stock | 4,160 | $84.09 | $349,814.40 |
DisclosureSEC source: 0001209191-22-061804 · doc4.xml · nonDerivative · entry 1 Chapman Harry S · CIK 0001500817 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,740 F1 · price: The price reported is a weighted average price $84.09 The shares were sold in multiple transactions at prices ranging from $84.00 to $84.90 per share, both inclusive. The reporting person undertakes to provide to U.S. Physical Therapy, Inc., any of its shareholders or the staff of the Securities & Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote to this Form 4. F2 · balance_after: Includes 800 shares of common stock which were granted as restricted stock pursuant to the Company Amended and Restated 2003 Stock Incentive Plan. Restrictions will lapse on the 400 shares on January 1, 2023, and 400 shares on April 1, 2023, if he is a director of the Company on that date. Read SEC document |
| December 15, 2022 Filed Dec 19, 2022 15:54 UTC | U S PHYSICAL THERAPY INC /NV USPH · Entity 379 | SaleCommon Stock | 43 | $86.06 | $3,700.58 |
DisclosureSEC source: 0001209191-22-061785 · doc4.xml · nonDerivative · entry 2 Chapman Harry S · CIK 0001500817 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,900 F1 · balance_after: Includes 800 shares of common stock which were granted as restricted stock pursuant to the Company Amended and Restated 2003 Stock Incentive Plan. Restrictions will lapse on the 400 shares on January 1, 2023, and 400 shares on April 1, 2023, if he is a director of the Company on that date. Read SEC document |
| December 15, 2022 Filed Dec 19, 2022 15:54 UTC | U S PHYSICAL THERAPY INC /NV USPH · Entity 379 | SaleCommon Stock | 2,957 | $86.00 | $254,302.00 |
DisclosureSEC source: 0001209191-22-061785 · doc4.xml · nonDerivative · entry 1 Chapman Harry S · CIK 0001500817 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,943 F1 · balance_after: Includes 800 shares of common stock which were granted as restricted stock pursuant to the Company Amended and Restated 2003 Stock Incentive Plan. Restrictions will lapse on the 400 shares on January 1, 2023, and 400 shares on April 1, 2023, if he is a director of the Company on that date. Read SEC document |
| December 02, 2022 Filed Dec 5, 2022 20:29 UTC | U S PHYSICAL THERAPY INC /NV USPH · Entity 379 | SaleCommon Stock | 8,600 | $90.82 | $781,052.00 |
DisclosureSEC source: 0001209191-22-059619 · doc4.xml · nonDerivative · entry 1 Chapman Harry S · CIK 0001500817 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 13,900 F1 · price: The price reported is a weighted average price $90.82. The shares were sold in multiple transactions at prices ranging from $90.70 to $91.03 per share, both inclusive. The reporting person undertakes to provide to U.S. Physical Therapy, Inc., any of its shareholders or the staff of the Securities & Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote to this Form 4. F2 · balance_after: Includes the 800 shares of common stock that were granted as restricted stock pursuant to the Company Amended and Restated 2003 Stock Incentive Plan. Restrictions lapse as to 400 shares lapsed on each of January 1, 2023 and April 1, 2023, if he is a director of the Company on those dates Read SEC document |
| September 12, 2022 Filed Sep 14, 2022 14:51 UTC | U S PHYSICAL THERAPY INC /NV USPH · Entity 379 | SaleCommon Stock | 3,000 | $80.50 | $241,500.00 |
DisclosureSEC source: 0001209191-22-049854 · doc4.xml · nonDerivative · entry 2 Chapman Harry S · CIK 0001500817 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 22,500 F1 · balance_after: Includes the 1,200 shares of common stock that were granted as restricted stock pursuant to the Company Amended and Restated 2003 Stock Incentive Plan. Restrictions lapse as to 400 shares lapsed on each of October 1, 2022, January 1, 2023 and April 1, 2023, if he is a director of the Company on those dates Read SEC document |
| September 12, 2022 Filed Sep 14, 2022 14:51 UTC | U S PHYSICAL THERAPY INC /NV USPH · Entity 379 | SaleCommon Stock | 2,000 | $80.50 | $161,000.00 |
DisclosureSEC source: 0001209191-22-049854 · doc4.xml · nonDerivative · entry 1 Chapman Harry S · CIK 0001500817 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 25,500 F1 · balance_after: Includes the 1,200 shares of common stock that were granted as restricted stock pursuant to the Company Amended and Restated 2003 Stock Incentive Plan. Restrictions lapse as to 400 shares lapsed on each of October 1, 2022, January 1, 2023 and April 1, 2023, if he is a director of the Company on those dates Read SEC document |
| September 06, 2022 Filed Sep 8, 2022 18:50 UTC | U S PHYSICAL THERAPY INC /NV USPH · Entity 379 | SaleCommon Stock | 3,000 | $76.73 | $230,190.00 |
DisclosureSEC source: 0001209191-22-049131 · doc4.xml · nonDerivative · entry 2 Chapman Harry S · CIK 0001500817 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 27,500 F1 · balance_after: Includes the 1,200 shares of common stock that were granted as restricted stock pursuant to the Company Amended and Restated 2003 Stock Incentive Plan. Restrictions lapse as to 400 shares lapsed on each of October 1, 2022, January 1, 2023 and April 1, 2023, if he is a director of the Company on those dates. Read SEC document |
| September 06, 2022 Filed Sep 8, 2022 18:50 UTC | U S PHYSICAL THERAPY INC /NV USPH · Entity 379 | SaleCommon Stock | 2,000 | $76.70 | $153,400.00 |
DisclosureSEC source: 0001209191-22-049131 · doc4.xml · nonDerivative · entry 1 Chapman Harry S · CIK 0001500817 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 30,500 F1 · balance_after: Includes the 1,200 shares of common stock that were granted as restricted stock pursuant to the Company Amended and Restated 2003 Stock Incentive Plan. Restrictions lapse as to 400 shares lapsed on each of October 1, 2022, January 1, 2023 and April 1, 2023, if he is a director of the Company on those dates. Read SEC document |
| May 16, 2022 Filed May 18, 2022 15:46 UTC | U S PHYSICAL THERAPY INC /NV USPH · Entity 379 | GrantCommon Stock | 1,600 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-22-029940 · doc4.xml · nonDerivative · entry 1 Chapman Harry S · CIK 0001500817 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 32,500 F1 · shares: The 1,600 shares of common stock were granted as restricted stock pursuant to the Company Amended and Restated 2003 Stock Incentive Plan. Restrictions lapse as to 400 shares lapsed on each of July 1, 2022, October 1, 2022, January 1, 2023 and April 1, 2023, if he is a director of the Company on those dates. F2 · balance_after: Includes the 1,600 shares of restricted stock granted under the Company equity plans mentioned in Note 1. Read SEC document |
| March 17, 2022 Filed Mar 18, 2022 18:04 UTC | U S PHYSICAL THERAPY INC /NV USPH · Entity 379 | SaleCommon Stock | 1,280 | $96.02 | $122,905.60 |
DisclosureSEC source: 0001209191-22-019981 · doc4.xml · nonDerivative · entry 1 Chapman Harry S · CIK 0001500817 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 30,900 F1 · balance_after: Includes 370 shares of common stock which were granted as restricted stock pursuant to the Company Amended and Restated 2003 Stock Incentive Plan. Restrictions lapse as of April 1, 2022. If he is a director of the Company on that date. Read SEC document |
| March 15, 2022 Filed Mar 17, 2022 14:00 UTC | U S PHYSICAL THERAPY INC /NV USPH · Entity 379 | SaleCommon Stock | 100 | $94.91 | $9,491.00 |
DisclosureSEC source: 0001209191-22-019422 · doc4.xml · nonDerivative · entry 4 Chapman Harry S · CIK 0001500817 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 32,180 F1 · balance_after: Includes 370 shares of common stock which were granted as restricted stock pursuant to the Company Amended and Restated 2003 Stock Incentive Plan. Restrictions lapse on April 1, 2022, if he is a director of the Company on that date. Read SEC document |
| March 15, 2022 Filed Mar 17, 2022 14:00 UTC | U S PHYSICAL THERAPY INC /NV USPH · Entity 379 | SaleCommon Stock | 1,000 | $94.75 | $94,750.00 |
DisclosureSEC source: 0001209191-22-019422 · doc4.xml · nonDerivative · entry 3 Chapman Harry S · CIK 0001500817 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 32,280 F1 · balance_after: Includes 370 shares of common stock which were granted as restricted stock pursuant to the Company Amended and Restated 2003 Stock Incentive Plan. Restrictions lapse on April 1, 2022, if he is a director of the Company on that date. Read SEC document |
| March 15, 2022 Filed Mar 17, 2022 14:00 UTC | U S PHYSICAL THERAPY INC /NV USPH · Entity 379 | SaleCommon Stock | 1,000 | $94.75 | $94,750.00 |
DisclosureSEC source: 0001209191-22-019422 · doc4.xml · nonDerivative · entry 2 Chapman Harry S · CIK 0001500817 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 33,280 F1 · balance_after: Includes 370 shares of common stock which were granted as restricted stock pursuant to the Company Amended and Restated 2003 Stock Incentive Plan. Restrictions lapse on April 1, 2022, if he is a director of the Company on that date. Read SEC document |
| March 15, 2022 Filed Mar 17, 2022 14:00 UTC | U S PHYSICAL THERAPY INC /NV USPH · Entity 379 | SaleCommon Stock | 1,220 | $94.75 | $115,595.00 |
DisclosureSEC source: 0001209191-22-019422 · doc4.xml · nonDerivative · entry 1 Chapman Harry S · CIK 0001500817 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 34,280 F1 · balance_after: Includes 370 shares of common stock which were granted as restricted stock pursuant to the Company Amended and Restated 2003 Stock Incentive Plan. Restrictions lapse on April 1, 2022, if he is a director of the Company on that date. Read SEC document |
| August 27, 2021 Filed Aug 30, 2021 15:04 UTC | U S PHYSICAL THERAPY INC /NV USPH · Entity 379 | SaleCommon Stock | 1,000 | $116.07 | $116,070.00 |
DisclosureSEC source: 0001209191-21-053783 · doc4.xml · nonDerivative · entry 2 Chapman Harry S · CIK 0001500817 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 35,500 F1 · balance_after: Includes 1,110 shares of common stock which was granted as restricted stock pursuant to the Company Amended and Restated 2003 Stock Incentive Plan. Restrictions lapse as to 370 shares lapsed on each of October 1, 2021, January 1, 2022 and April 1, 2022, if he is a director of the Company on those dates. Read SEC document |
| August 27, 2021 Filed Aug 30, 2021 15:04 UTC | U S PHYSICAL THERAPY INC /NV USPH · Entity 379 | SaleCommon Stock | 1,000 | $116.16 | $116,160.00 |
DisclosureSEC source: 0001209191-21-053783 · doc4.xml · nonDerivative · entry 1 Chapman Harry S · CIK 0001500817 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 36,500 F1 · balance_after: Includes 1,110 shares of common stock which was granted as restricted stock pursuant to the Company Amended and Restated 2003 Stock Incentive Plan. Restrictions lapse as to 370 shares lapsed on each of October 1, 2021, January 1, 2022 and April 1, 2022, if he is a director of the Company on those dates. Read SEC document |
| August 06, 2021 Filed Aug 10, 2021 20:15 UTC | U S PHYSICAL THERAPY INC /NV USPH · Entity 379 | PurchaseCommon Stock | 520 | $118.64 | $61,692.80 |
DisclosureSEC source: 0001209191-21-050594 · doc4.xml · nonDerivative · entry 4 Chapman Harry S · CIK 0001500817 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 37,500 F1 · shares: Disgorgement has occurred, and was completed immediately upon knowledge that such disgorgement was necessary F2 · balance_after: Includes 1,110 shares of common stock which was granted as restricted stock pursuant to the Company Amended and Restated 2003 Stock Incentive Plan. Restrictions lapse as to 370 shares lapsed on each of October 1, 2021, January 1, 2022 and April 1, 2022, if he is a director of the Company on those dates. Read SEC document |
| August 06, 2021 Filed Aug 10, 2021 20:15 UTC | U S PHYSICAL THERAPY INC /NV USPH · Entity 379 | PurchaseCommon Stock | 480 | $117.83 | $56,558.40 |
DisclosureSEC source: 0001209191-21-050594 · doc4.xml · nonDerivative · entry 3 Chapman Harry S · CIK 0001500817 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 36,980 F1 · shares: Disgorgement has occurred, and was completed immediately upon knowledge that such disgorgement was necessary F2 · balance_after: Includes 1,110 shares of common stock which was granted as restricted stock pursuant to the Company Amended and Restated 2003 Stock Incentive Plan. Restrictions lapse as to 370 shares lapsed on each of October 1, 2021, January 1, 2022 and April 1, 2022, if he is a director of the Company on those dates. Read SEC document |
| August 06, 2021 Filed Aug 10, 2021 20:15 UTC | U S PHYSICAL THERAPY INC /NV USPH · Entity 379 | PurchaseCommon Stock | 520 | $117.50 | $61,100.00 |
DisclosureSEC source: 0001209191-21-050594 · doc4.xml · nonDerivative · entry 2 Chapman Harry S · CIK 0001500817 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 36,500 F1 · shares: Disgorgement has occurred, and was completed immediately upon knowledge that such disgorgement was necessary F2 · balance_after: Includes 1,110 shares of common stock which was granted as restricted stock pursuant to the Company Amended and Restated 2003 Stock Incentive Plan. Restrictions lapse as to 370 shares lapsed on each of October 1, 2021, January 1, 2022 and April 1, 2022, if he is a director of the Company on those dates. Read SEC document |
| August 06, 2021 Filed Aug 10, 2021 20:15 UTC | U S PHYSICAL THERAPY INC /NV USPH · Entity 379 | PurchaseCommon Stock | 500 | $113.35 | $56,675.00 |
DisclosureSEC source: 0001209191-21-050594 · doc4.xml · nonDerivative · entry 1 Chapman Harry S · CIK 0001500817 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 35,980 F1 · shares: Disgorgement has occurred, and was completed immediately upon knowledge that such disgorgement was necessary F2 · balance_after: Includes 1,110 shares of common stock which was granted as restricted stock pursuant to the Company Amended and Restated 2003 Stock Incentive Plan. Restrictions lapse as to 370 shares lapsed on each of October 1, 2021, January 1, 2022 and April 1, 2022, if he is a director of the Company on those dates. Read SEC document |
| May 17, 2021 Filed May 19, 2021 15:25 UTC | U S PHYSICAL THERAPY INC /NV USPH · Entity 379 | GrantCommon Stock | 1,480 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-21-033888 · doc4.xml · nonDerivative · entry 1 Chapman Harry S · CIK 0001500817 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 35,480 F1 · shares: The 1,480 shares of common stock was granted as restricted stock pursuant to the Company Amended and Restated 2003 Stock Incentive Plan. Restrictions lapse as to 370 shares lapsed on each of July 1, 2021, October 1, 2021, January 1, 2022 and April 1, 2022, if he is a director of the Company on those dates. F2 · balance_after: Includes the 1,480 shares of restricted stock granted under the Company equity plans mentioned in Note 1. Read SEC document |
| March 25, 2021 Filed Mar 26, 2021 13:57 UTC | U S PHYSICAL THERAPY INC /NV USPH · Entity 379 | PurchaseCommon Stock | 1,000 | $108.00 | $108,000.00 |
DisclosureSEC source: 0001209191-21-023151 · doc4.xml · nonDerivative · entry 8 Chapman Harry S · CIK 0001500817 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 34,000 F2 · shares: This purchase transaction was inadvertent and the required disgorgement already has occurred. F1 · balance_after: Includes 400 shares of common stock which was granted as restricted stock pursuant to the Company Amended and Restated 2003 Stock Incentive Plan. Restrictions will lapse on the 400 shares on April 1, 2021, if he is a director of the Company on that date. Read SEC document |
| March 25, 2021 Filed Mar 26, 2021 13:57 UTC | U S PHYSICAL THERAPY INC /NV USPH · Entity 379 | SaleCommon Stock | 2,000 | $107.77 | $215,540.00 |
DisclosureSEC source: 0001209191-21-023151 · doc4.xml · nonDerivative · entry 7 Chapman Harry S · CIK 0001500817 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 33,000 F1 · balance_after: Includes 400 shares of common stock which was granted as restricted stock pursuant to the Company Amended and Restated 2003 Stock Incentive Plan. Restrictions will lapse on the 400 shares on April 1, 2021, if he is a director of the Company on that date. Read SEC document |
| March 25, 2021 Filed Mar 26, 2021 13:57 UTC | U S PHYSICAL THERAPY INC /NV USPH · Entity 379 | SaleCommon Stock | 1,000 | $106.10 | $106,100.00 |
DisclosureSEC source: 0001209191-21-023151 · doc4.xml · nonDerivative · entry 6 Chapman Harry S · CIK 0001500817 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 35,000 F1 · balance_after: Includes 400 shares of common stock which was granted as restricted stock pursuant to the Company Amended and Restated 2003 Stock Incentive Plan. Restrictions will lapse on the 400 shares on April 1, 2021, if he is a director of the Company on that date. Read SEC document |
| March 22, 2021 Filed Mar 26, 2021 13:57 UTC | U S PHYSICAL THERAPY INC /NV USPH · Entity 379 | SaleCommon Stock | 1,000 | $120.82 | $120,820.00 |
DisclosureSEC source: 0001209191-21-023151 · doc4.xml · nonDerivative · entry 5 Chapman Harry S · CIK 0001500817 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 36,000 F1 · balance_after: Includes 400 shares of common stock which was granted as restricted stock pursuant to the Company Amended and Restated 2003 Stock Incentive Plan. Restrictions will lapse on the 400 shares on April 1, 2021, if he is a director of the Company on that date. Read SEC document |
| March 18, 2021 Filed Mar 26, 2021 13:57 UTC | U S PHYSICAL THERAPY INC /NV USPH · Entity 379 | SaleCommon Stock | 1,000 | $120.52 | $120,520.00 |
DisclosureSEC source: 0001209191-21-023151 · doc4.xml · nonDerivative · entry 4 Chapman Harry S · CIK 0001500817 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 37,000 F1 · balance_after: Includes 400 shares of common stock which was granted as restricted stock pursuant to the Company Amended and Restated 2003 Stock Incentive Plan. Restrictions will lapse on the 400 shares on April 1, 2021, if he is a director of the Company on that date. Read SEC document |
| March 18, 2021 Filed Mar 26, 2021 13:57 UTC | U S PHYSICAL THERAPY INC /NV USPH · Entity 379 | SaleCommon Stock | 1,000 | $120.16 | $120,160.00 |
DisclosureSEC source: 0001209191-21-023151 · doc4.xml · nonDerivative · entry 3 Chapman Harry S · CIK 0001500817 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 38,000 F1 · balance_after: Includes 400 shares of common stock which was granted as restricted stock pursuant to the Company Amended and Restated 2003 Stock Incentive Plan. Restrictions will lapse on the 400 shares on April 1, 2021, if he is a director of the Company on that date. Read SEC document |
| March 17, 2021 Filed Mar 26, 2021 13:57 UTC | U S PHYSICAL THERAPY INC /NV USPH · Entity 379 | SaleCommon Stock | 1,000 | $119.10 | $119,100.00 |
DisclosureSEC source: 0001209191-21-023151 · doc4.xml · nonDerivative · entry 2 Chapman Harry S · CIK 0001500817 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 39,000 F1 · balance_after: Includes 400 shares of common stock which was granted as restricted stock pursuant to the Company Amended and Restated 2003 Stock Incentive Plan. Restrictions will lapse on the 400 shares on April 1, 2021, if he is a director of the Company on that date. Read SEC document |
| March 17, 2021 Filed Mar 26, 2021 13:57 UTC | U S PHYSICAL THERAPY INC /NV USPH · Entity 379 | SaleCommon Stock | 1,000 | $118.47 | $118,470.00 |
DisclosureSEC source: 0001209191-21-023151 · doc4.xml · nonDerivative · entry 1 Chapman Harry S · CIK 0001500817 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 40,000 F1 · balance_after: Includes 400 shares of common stock which was granted as restricted stock pursuant to the Company Amended and Restated 2003 Stock Incentive Plan. Restrictions will lapse on the 400 shares on April 1, 2021, if he is a director of the Company on that date. Read SEC document |
| August 18, 2020 Filed Aug 19, 2020 13:33 UTC | U S PHYSICAL THERAPY INC /NV USPH · Entity 379 | GrantCommon Stock | 1,600 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-20-047416 · doc4.xml · nonDerivative · entry 1 Chapman Harry S · CIK 0001500817 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 41,000 F1 · shares: The 1,600 shares of common stock were granted as restricted stock pursuant to the Company Amended and Restated 2003 Stock Incentive Plan. Restrictions lapse for 400 shares upon grant and 400 shares on each of October 1, 2020 and January 1 and April 1, 2021, if he is a director of the Company on those dates. F2 · balance_after: Includes the 1,600 shares noted in above footnote. Read SEC document |
| March 18, 2020 Filed Mar 19, 2020 14:52 UTC | U S PHYSICAL THERAPY INC /NV USPH · Entity 379 | SaleCommon Stock | 7,000 | $54.02 | $378,140.00 |
DisclosureSEC source: 0001209191-20-020184 · doc4.xml · nonDerivative · entry 1 Chapman Harry S · CIK 0001500817 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 39,400 F1 · balance_after: Includes 400 shares of common stock which was granted as restricted stock pursuant to the Company's Amended and Restated 2003 Stock Incentive Plan. Restrictions will lapse on the 400 shares on April 1, 2020, if he is a director of the Company on that date. Read SEC document |
| November 11, 2019 Filed Nov 13, 2019 18:59 UTC | U S PHYSICAL THERAPY INC /NV USPH · Entity 379 | PurchaseCommon Stock | 2,400 | $117.00 | $280,800.00 |
DisclosureSEC source: 0001209191-19-056302 · doc4.xml · nonDerivative · entry 1 Chapman Harry S · CIK 0001500817 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 46,400 F1 · balance_after: Includes 800 shares of common stock which was granted as restricted stock pursuant to the Company's Amended and Restated 2003 Stock Incentive Plan. Restrictions will lapse on the 400 shares on each of January 1, 2020 and April 1, 2020, if he is a director of the Company on those dates. Read SEC document |
| May 20, 2019 Filed May 22, 2019 18:59 UTC | U S PHYSICAL THERAPY INC /NV USPH · Entity 379 | GrantCommon Stock | 1,600 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-19-031984 · doc4.xml · nonDerivative · entry 1 Chapman Harry S · CIK 0001500817 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 44,000 F1 · shares: The 1,600 shares of common stock was granted as restricted stock pursuant to the Company's Amended and Restated 2003 Stock Incentive Plan. Restrictions lapse as to 400 shares lapsed on each of July 1, 2019, October 1, 2019, January 1, 2020 and April 1, 2020, if he is a director of the Company on those dates. F2 · balance_after: Includes the 1,600 shares discussed in Note 1. Read SEC document |
| March 18, 2019 Filed Mar 20, 2019 14:10 UTC | U S PHYSICAL THERAPY INC /NV USPH · Entity 379 | PurchaseCommon Stock | 950 | $105.33 | $100,063.50 |
DisclosureSEC source: 0001209191-19-020520 · doc4.xml · nonDerivative · entry 1 Chapman Harry S · CIK 0001500817 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 42,400 F1 · balance_after: Includes 500 shares of restricted stock granted under the Company's equity plans which restrictions lapse on April 1, 2019. Read SEC document |
| December 11, 2018 Filed Dec 13, 2018 13:52 UTC | U S PHYSICAL THERAPY INC /NV USPH · Entity 379 | PurchaseCommon Stock | 1,200 | $110.69 | $132,828.00 |
DisclosureSEC source: 0001209191-18-062359 · doc4.xml · nonDerivative · entry 1 Chapman Harry S · CIK 0001500817 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 41,450 F1 · balance_after: Includes 1,000 shares of common stock which was granted as restricted stock pursuant to the Company's Amended and Restated 2003 Stock Incentive Plan. Restrictions will lapse on the 500 shares on each of January 1, 2019 and April 1, 2019. Read SEC document |
| May 22, 2018 Filed May 23, 2018 17:58 UTC | U S PHYSICAL THERAPY INC /NV USPH · Entity 379 | GrantCommon Stock | 2,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-18-032522 · doc4.xml · nonDerivative · entry 1 Chapman Harry S · CIK 0001500817 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 40,250 F1 · shares: The 2,000 shares of common stock was granted as restricted stock pursuant to the Company's Amended and Restated 2003 Stock Incentive Plan. Restrictions lapse as to 500 shares lapsed on each of July 1, 2018, October 1, 2018, January 1, 2019 and April 1, 2019, if he is a director of the Company on those dates. F2 · balance_after: Includes the 2,000 shares discussed in Note 1. Read SEC document |
| October 03, 2017 Filed Oct 6, 2017 00:19 UTC | U S PHYSICAL THERAPY INC /NV USPH · Entity 379 | GrantCommon Stock | 2,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-17-056226 · doc4.xml · nonDerivative · entry 1 Chapman Harry S · CIK 0001500817 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 38,250 F1 · shares: The 2,000 shares of common stock was granted as restricted stock pursuant to the Company's Amended and Restated 2003 Stock Incentive Plan. Restrictions lapsed as to 1,000 on the date of grant, October 3, 2017, for the remaining 1,000 shares 500 will lapse on each of January 1, 2018, and April 1, 2018, if he is a director of the Company on those dates. F2 · balance_after: Includes the 2,000 shares discussed in Note 1. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.